GlobeNewsWire
20 Feb 2026, 21:01 UTC · 30w ago
Verdict
Headline takes no side. We score FOLD +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 83% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
The proposed acquisition of Amicus Therapeutics by BioMarin is expected to close in Q2 2026, subject to closing conditions.
So whatThe definitive acquisition agreement provides a clear, binary catalyst for both companies' shareholders, significantly impacting share price valuations and risk profiles until the deal closes.
More positive than 99% of claims this week
Amicus Therapeutics reported full-year 2025 total revenue of $634M, up 17% year-over-year at constant exchange rates.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 87% of claims this week
Amicus Therapeutics' cash position increased by $44M in 2025 to end the year at $294M.
More positive than 69% of claims this week
Due to the pending acquisition by BioMarin, Amicus is not providing financial guidance for 2026 and will not host a quarterly conference call.
So whatThe suspension of guidance and earnings calls removes near-term forward-looking information for standalone valuation, though the impact is largely mitigated by the pending acquisition dynamics.
More negative than 66% of claims this week
Which stocks this story touches
More positive than 83% of ticker scores this week
Reported 17% year-over-year revenue growth and an increased cash position, alongside a pending acquisition.
More positive than 58% of ticker scores this week
Expanding its portfolio through the proposed acquisition of Amicus Therapeutics.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
2h ago
+1.0%
Price agrees with the score
$14.49 vs $14.34 close before publication (Feb 20) · not market-adjusted
FOLD chart →
